Medicare Enrolled
Dr. Nilesh Patel, MD
Infectious Disease · Glendora, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Patel
Dr. Nilesh Patel is an infectious disease specialist in Glendora, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Patel performed 14,881 Medicare services across 2,970 unique beneficiaries.
Between the years covered by Open Payments, Dr. Patel received a total of $5,028 from 22 pharmaceutical and/or device companies across 236 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in infectious disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Patel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 1% volume in CA
$5,028 industry payments
Medicare Practice Summary
Medicare Utilization ↗14,881
Medicare services
Top 1% in CA for infectious disease
2,970
Unique beneficiaries
$61
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~744 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
5,990 | $67 | $199 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
2,392 | $101 | $299 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
1,464 | $12 | $100 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
698 | $0 | $10 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
582 | $1 | $10 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
506 | $64 | $85 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
435 | $107 | $300 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
381 | $27 | $35 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
293 | $110 | $400 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
287 | $74 | $250 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
251 | $0 | $100 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
229 | $0 | $10 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
228 | $42 | $100 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
202 | $44 | $150 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
167 | $147 | $500 |
| Injection, cefepime hydrochloride, 500 mg | 135 | $1 | $25 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
120 | $179 | $500 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
94 | $73 | $150 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
59 | $34 | $100 |
| Home health agency supervision, complex multidisciplinary care Supervision by a physician or allowed practitioner for a patient receiving Medicare-covered services from a participating home health agency. This involves complex and multidisciplinary care modalities, with the patient not present during the supervision. |
54 | $90 | $250 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
46 | $72 | $100 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
45 | $142 | $150 |
| Promethazine HCl injection, up to 50 mg Administration of promethazine hydrochloride medication via injection for doses up to 50 mg. |
41 | $2 | $25 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
39 | $46 | $250 |
| Home health plan of care re-certification A physician reviews the patient's status and contacts the home health agency to re-certify the plan of care without the patient being present. |
24 | $37 | $250 |
| Burn dressing change or tissue removal, less than 5% body surface This procedure involves changing dressings or removing dead tissue from a burn wound covering less than 5% of the total body surface area. |
23 | $74 | $100 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
21 | $84 | $300 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
19 | $128 | $400 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
16 | $34 | $100 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
14 | $69 | $200 |
| Pneumococcal vaccine, 13-valent | 13 | $253 | $400 |
| Quadrivalent influenza vaccine, preservative-free A flu shot containing four strains of the influenza virus, formulated without preservatives, administered in a 0.5 ml dose. |
13 | $22 | $100 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$5,028
Total received (2018-2024)
Avg $718/year across 7 years
Top 21% in CA for infectious disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
22
Companies
236
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,028 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,022
2023
$832
2022
$1,141
2021
$418
2020
$437
2019
$705
2018
$473
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$246
Gilead Sciences, Inc.
$214
Shionogi Inc
$153
PFIZER INC.
$122
ViiV Healthcare Company
$81
Merck Sharp & Dohme LLC
$81
Paratek Pharmaceuticals, Inc.
$68
ABBVIE INC.
$57
Top 3 companies account for 60.0% of 2024 payments
All-time payments by company (2018-2024) ›
Gilead Sciences, Inc.
$1,150
Cumberland Pharmaceuticals, Inc.
$818
GlaxoSmithKline, LLC.
$471
ViiV Healthcare Company
$448
Shionogi Inc
$399
Merck Sharp & Dohme Corporation
$346
Philips Electronics North America Corporation
$314
Merck Sharp & Dohme LLC
$229
ABBVIE INC.
$178
PFIZER INC.
$135
Stryker Corporation
$113
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$97
Paratek Pharmaceuticals, Inc.
$90
Melinta Therapeutics, LLC
$52
Chiesi USA, Inc.
$41
Melinta Therapeutics, Inc.
$41
SANOFI PASTEUR INC.
$22
Allergan, Inc.
$19
Horizon Therapeutics plc
$18
Theratechnologies Inc.
$16
Dynavax Technologies Corporation
$16
Insmed, Inc.
$13
Top 3 companies account for 48.5% of all-time payments
Associated products mentioned in payments ›
ABRYSVO · AREXVY · AVYCAZ · Arikayce · CABENUVA · DALVANCE · DIFICID · DOVATO · EUCRISA · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · Fetroja · Heplisav-B · ISENTRESS · IVS - IVAS · KENGREAL · MENVEO · NUZYRA · PENNSAID · RECARBRIO · SHINGRIX · TROGARZO · Trilogy 100 · VERSITOMIC · VIBATIV · Vabomere · Vibativ · XIFAXAN · ZEPATIER · ZERBAXA · ZINPLAVA · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Infectious diseases within 10 mi
136
Per 100K population
1.4
County median income
$87,760
Nearest hospital
EMANATE HEALTH FOOTHILL PRESBYTERIAN HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Patel is a mixed practice specialist, with above-average Medicare volume (top 1% in CA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Patel experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Patel performed 5,990 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $5,028 from 22 companies across 236 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Patel's costs compare to other infectious diseases in Glendora?
Dr. Patel's average Medicare payment per service is $61. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Infectious Diseases in Glendora
Browse infectious diseases in Glendora ranked by procedure volume and transparency data.
Highest volume
Top Infectious Diseases in CA
Infectious diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Infectious Diseases in CA
Which CA infectious diseases receive the most from drug and device companies.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
By company
Cumberland Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Cumberland Pharmaceuticals, Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology